Poland debates access to costly therapies vs. public budget constraints
Published 1 d ago1 sourceEvidence: Reported
Slovak President Peter Pellegrini signed a major healthcare reform aimed at clarifying reimbursement rules, protecting public finances, and curbing illegal drug exports. The reform strengthens control over the pharmaceutical supply chain, though implementation details and impact on stakeholders remain unclear. This marks a significant domestic policy shift with potential implications for drug pricing and availability in Slovakia.
Entities
Published 1 d ago1 sourceEvidence: Reported
Published 4 h ago13 sourcesEvidence: Reported
Published 1 d ago5 sourcesEvidence: Reported
Published 1 d ago5 sourcesEvidence: Reported
Published 1 d ago10 sourcesEvidence: Reported
Published 1 d ago4 sourcesEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported